Accuray touts 2 radiation therapy studies
February 6, 2020 -- Radiation oncology firm Accuray is touting results from two studies that investigate the efficacy of its TomoHelical therapy system to treat advanced rectal cancer.
Eckert & Ziegler to open U.S. isotope facility
February 6, 2020 -- Isotope technology firm Eckert & Ziegler has unveiled plans to open a radiopharmaceutical production site in Massachusetts.
IsoRay, MIM Software team on treatment for head, neck cancer
February 5, 2020 -- Medical isotope developer IsoRay will collaborate with medical imaging software developer MIM Software to improve treatment for head and neck cancer.
Varian posts strong Q1 sales growth as profit slips
January 30, 2020 -- Radiation therapy firm Varian Medical Systems reported 13% growth in revenues for the first quarter of fiscal 2020. The company's net income slipped for the period, however, due mostly to the effect of a large one-time gain in last year's numbers.
Accuray posts mixed Q2 results
January 29, 2020 -- Despite a decline in overall revenue, radiation oncology firm Accuray posted net income for its second quarter and first six months of fiscal 2020.
Should cancer centers ban the bell?
January 24, 2020 -- Bells have become commonplace within oncology centers as a means to allow cancer patients to mark the end of their course of treatment. But is it time to ban the bell? A new study published in International Journal of Radiation Oncology, Biology, Physics suggests it might.  Discuss
Shine reports Lu-177 production milestone
January 22, 2020 -- Medical isotope firm Shine Medical Technologies and partners GE Healthcare and the Institute of Organic Chemistry and Biochemistry in the Czech Republic said they have produced patient dose quantities of the lutetium-177 (Lu-177) therapeutic isotope.
ASRT: Enrollment down for radiologic technology programs
January 15, 2020 -- The number of students enrolling in radiologic technology programs trended downward in 2019, according to a report released by the American Society of Radiologic Technologists (ASRT).
ViewRay expects revenue growth in 2019, despite slow Q4
January 13, 2020 -- Image-guided radiation therapy vendor ViewRay reported in its preliminary results a growth in total revenue of roughly 8% for its fiscal 2019, despite a large drop in orders in its fourth quarter.
Accuray touts CyberKnife study results
January 9, 2020 -- Radiation oncology firm Accuray is touting the results of a prospective study in which stereotactic body radiation therapy performed with its CyberKnife system provided excellent disease control at the five-year mark for men with locally recurrent prostate cancer.
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more